期刊
ONCOTARGET
卷 7, 期 28, 页码 44350-44364出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.10051
关键词
miR-186; mPGES-1/PGE-2; VEGF; prostate cancer; tumor angiogenesis
资金
- Associazione Italiana sul Cancro [IG10731]
Prostaglandin E-2 (PGE-2) promotes tumor angiogenesis via paracrine secretion of pro-angiogenic growth factors, such as vascular endothelial growth factor (VEGF). Since miRNAs regulate several cell processes, including angiogenesis, we sought to determine whether they would influence PGE-2-induced VEGF. We compared DU145 and PC3 prostate cancer cells bearing the mPGES-1 enzyme (mPGES-1(+/+)) and producing PGE-2, with those in which the enzyme was silenced or deleted (mPGES-1(-/-)). We demonstrated that mPGES-1/PGE-2 signaling decreased Dicer expression and miRNA biogenesis. Genome-wide sequencing of miRNAs revealed that miR-15a and miR-186, associated with expression of VEGF and hypoxia inducible factor-1 alpha (HIF-1 alpha), were down-regulated in mPGES-1(+/+) cells. As a consequence, mPGES-1(+/+) tumor cells expressed high levels of VEGF and HIF-1 alpha, induced endothelial cells activation and formed highly vascularized tumors. Mir-186 mimic inhibited VEGF expression in mPGES-1(+/+) tumor xenografts and reduced tumor growth. In human prostate cancer specimens, mPGES-1 was over-expressed in tumors with high Gleason score, elevated expression of VEGF and HIF-1a, high microvessel density and decreased expression of Dicer, miR15a and miR-186. Thus, clear evidence for regulating miRNA processing and VEGF output by intrinsic PGE-2 production provides a means to distinguish between aggressive and indolent prostate tumors and suggests a potential target for controlling tumor progression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据